Lilly
FDA Authorizes Baricitinib Alone as COVID-19 Treatment
The FDA revised the emergency use authorization (EUA) for baricitinib to enable its use alone for the treatment of ...
JULY 29, 2021
FDA Approves First Treatment for Episodic Cluster Headache
People with episodic cluster headache represent 85% to 90% of cluster headache prevalence, with approximately ...
JUNE 5, 2019
Load more